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In an immunohistopathologic study using two mono-
clonal antibodies that recognize independent epitopes 
on human thrombomodulin, we detected expression 
of' thrombomodulin on Malpighian-Iayer keratino-
cytes, but not on the basal or upper granular-layer 
keratinocytes. Western blotting and thrombomod-
ulin-specific enzyme-linked immunosorbent assay 
performed on both shaved skin and cultured SV 40-
transformed keratinocytes showed the expression of 
full-length thrombomodulin, indistinguishable from 
endothelial thrombomodulin. Thrombomodulin was 
T hrombomodulin (TM) is an integral membrane pro-tein on the surface of endothelial cells. It acts as an anticoagulant by serving as a cofactor in the activation of protein C after thrombin binding to TM [1]. Re-cently, a mouse protein relevant to fetal development, 
fetomodulin, was revealed as identical to TM [2]. The immunohis-
tologic distribution of fetomodulin was reported in the various 
organs of the fetal mouse in. this s~~dy. T?e results impl~ another 
potential role of human TM 111 addition to Its .rol~ as ~n antlcoagul~­
tion factor. However, reports about the dlstnbutlon of TM 111 
humans are limited to those involving vascular endothelial cells [3]. 
The skin is an organ that shows irreversible constitutive differentia-
t ion and proliferation from basal keratinocytes to horny layer ~ells. 
In this study, we found immunoreactive TM in the normal epIder-
mis. This TM can function as an anticoagulation protein in biologic 
assays, similar to its counterpart on dermal endothelial cells. Fur-
thermore, the suprabasal keratinocyte-specific distribution in skin, 
as well as the induction study in cultured keratinocytes, suggest that 
TM is also a specific differentiation marker for keratinocytes. 
MATERIALS AND METHODS 
Monoclonal Antibodies to TM Mouse monoclonal IgGs for human TM 
(MFTM-S and MFTM-6) were raised and purified as we reported previously 
[4). MFTM-S recognized the fifth epidermal growth factor domain from the 
NH2-terminus of six epidermal growth factor domains in TM, which con-
tains a thrombin-binding site, and competed with thrombin for binding to 
TM [4). MFTM-6 recognizes a non-thrombin -binding site ofTM, does not 
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expressed by keratinocytes in 1 mM calcium but not in 
reduced calcium. A functional assay for thrombomod-
ulin revealed that epidermal-derived thrombomodu-
lin possessed cofactor activity for thrombin-catalyzed 
protein C activation. The limited pattern of expression 
of thrombomodulin in epidermis implies that this 
molecule may be a differentiation marker ofkeratino-
cytes in addition to being a potent anticoagulant in the 
skin. Key words: tltrombomodulin/protein C/anticoagula-
tion/differentiation. ] Invest Dermato1103:825 -828, 1994 
compete with MFTM-5, and reacts to natu ral or nonreduced TM but not to 
reduced TM in W estern blotting (data not shown). 
Immunohistochemical Study Freshly obtained, 6-mm punch biopsy 
skin specimens from healthy volunteers were snap frozen and stored at 
-70·C after fixing with poly-L-Iysine paraformaldehyde solution or with-
out fixation. Sections of 5 f.lm on poly-L-Iysine-coated slides were incu-
bated with .l f.lg/ml of MFTM~S or MFTM-6 antibody as the first antibody 
after .blockmg by normal rabbIt ser~. RabbIt antI-mouse IgG coupled with 
alkalme phosphatase and antl-alkalme phosphatase antibody complex was 
used as the second antibody complex, then developed with fast red substrates 
(APPAP Kit, DAKO-Japan, Kyoto). 
Western Blotting The cellular extracts, skin samples, and purified pla-
cental TM were electrophoresed with sodium dodecyl sulfate-polyacrylam-
Ide g~1 electrophoresIs (SDS-PAGE) under nonreducing conditions, and the 
proteltls m the gel were transferred onto a nitrocellulose membrane (S & S, 
Dassel, Germany). After blocking with 1 % skim milk, the membrane was 
stained with monoclonal anti-TM IgG (MFTM-5 or MFTM-6) and alkaline 
phosphatase-coupled rabbit anti-mouse IgG antibody (Promega, Madison, 
WI). Immunoreactive protein bands were developed by Western-Blue 
(Promega). 
Recombinant Human TM The recombinant human TM was purified 
from culture medIUm of Ch111ese hamster ovary cells transfected with the 
cDNA encoding a soluble TM, in which a transmembrane domain and a 
COOH-terminal cytoplasmic domain were deleted from the intact form of 
human TM, as we reported previously [1). The recombinant human TM was 
purified by affinity chromatography using a thrombin-coupled Sepharose 
4B column, as described [1). 
Placental TM A natura'! TM was extracted from a human placental cell 
membrane fraction by using 1 % Triton X-I00 solution and purified by 
aHinity chromatography using the thrombin-coupled Sepharose 4B column 
as described [5]. 
Skin TM Sample Epidermal sheet skin specimens were shaved by kerato-
tome from normal skin of healthy volunteers during plastic surgery opera-
tions. The shaved skin specimens were split into small pieces by scalpel and 
treated with 0.5% Triton X-I00 (Sigma, St. Louis, MO) in Tris-buffered 
saline consisting of 0.05 M Tris-HCI and 0.1 M NaCl, pH 7.5, for 1 h at 
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4 ° C. The extract samples then were centrifuged at 15:000 rpm for 10 min at 
4 ° C. The supernatant was collected and stored at -20 ° C until use. 
TM Samples From Cultured Cells Normal human keratinocytes 
(NHK) and normal human umbilical vein endothelial cells (HUVEC) were 
purchased as Epi-pack and Endo-pack from Sanko-junyaku (Tokyo, Japan) 
and cultured with serum-free, low-calcium (0.1 mM), modified MCDB 153 
keratinocytes growth media (KGM) and endothelial cell growth media 
(Kurabo, Tokyo, Japan), respectively. The SV 40-transformed keratinocytes 
cell line (STKC) was a gift from Dr. Kupper (Boston, MA). Cells were 
cultured with Dulbecco's modification of Eagle's medium (DME) contain-
ing 10% (v/v) low endotoxin fetal bovine serum (Biocell, Rancho Domin-
guez, CA). Normal human fibroblast was cultured from the dermal skin 
from biopsy specimens of healthy volunteers with 10% low fetal bovine 
serum DME, which was used within five passages. The extracts were pre-
pared as were the skin TM samples. 
Induction of TM on NHK NHK were split and cultured in six-well 
plates (Costar, Cambridge, MA) with KGM. The subconfluently cultured 
NHK were washed with phosphate-buffered saline and cultured with either 
KGM, KGM with 1 mM calcium, or MCDB 153, and DME with 10% fetal 
bovine serum for 24 h. Cells were extracted with 0.5% Triton X-I00 in 
Tris-buffered saline as described above. 
Protein Concentration of Samples The protein concentration of the 
cellular extract was determined using the BCA protein assay kit (Pierce, 
Rockford, IL). 
Concentration ofTM in Cellular Extracts TM concentration of the 
cellular extracts was determined by a solid-phase sandwich ellZyme-linked 
immunosorbent assay (ELISA) system reported previously [6]. Serial dilu-
tions of purified human TM and cellular extracts were applied to MFTM-5-
coated microwell plates (Sumitomo, Tokyo, Japan). After a 2-h incubation 
at room temperature, the plates were washed and a peroxidase-coupled 
MFTM-6 was applied as the second antibody, then developed with ortho-
phenylene diamine as a substrate. The absorbance of the microwells was 
measured by microplate reader (Bio-rad, Hercules, CA) at 570 nm. The TM 
concentration of the samples was obtained from the standard curve prepared 
from known concentrations of purified human placental TM. 
Determination of Protein C-Activating Cofactor Activity of 
TM The cofactor activity of the cellular extracts was determined as re-
ported previously [7]. Briefly, 30 ttl ofTris-buffered saline containing 0.2% 
bovine serum albumin and 10 mM CaCI2 , 10 ttl of human thrombin (1 
ttg/ml) , and 20 ttl of protein C (100 ttg/ml) was mixed with the cellular 
extract or recombinant human TM series diluted with Tris-buffered saline 
containing 0.5% Triton X-l 00 as standards, and the mixture was incubated 
at 37 °C for 1 h. The reaction was stopped by the addition of antithrombin III 
(2ttg/rnl) and heparin (1 U/ml). The amount of activated protein C formed 
in 100 ttl of the incubation mixture was determined by incubation with 2 rnl 
of 200 ttM Boc-Leu-Ser-Thr-Arg-MCA (Protein Research Foundation, 
Osaka, Japan) in a buffer consisting of 0.05 M Tris-HCI and 0.1 M CsCI, pH 
8.0. The fluorescence of the released 4-aminomethylcoumarin was deter-
mined fluorospectrophotometrically with 440 nm emission and 380 run 
excitation [4] . All assays were performed in triplicate or duplicate. 
RESULTS 
Immunohistopathologic Study The specimens from normal 
skin showed significant expression of immunoreactive TM on kera-
tinocytes in the epidermis, as detected by both MFTM-5 and 
MFTM-6 (Fig 1). The TM expressed on the upper epidermis 
stained with a characteristic "basket weave" pattern; however, TM 
was scarcely detectable on the basal keratinocytes. The suprabasal 
keratinocytes directly adjacent to the basal layer showed the most 
extensive immunoreactivity. The intensity of TM staining was 
maintained throughout the Malpighian layer. Immunodetectable 
TM decreased gradually in the granular layer and then disappeared 
abruptly in the horny layer. 
In the dermis, dermal capillaries, arterial endothelial cells, and 
lymph vessels showed immunoreactivity ofTM comparable in in-
tensity to that of epidermal keratinocytes. Hair follicular epidermis 
also stained positively, except for the basal layer or the inner layer 
from the trichohyalin keratinization, in the same manner as epider-
mis. TM was not detectable on the nerve fibers, pillar muscles, 
eccrine sweat glands, apocrine glands, sebaceous glands, or collagen 
fibers. Dermal and intraepidermal eccrine ducts and myoepithelial 
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Figure 1. Frozen section of normal human skin stained with 
MFTM-S. This shows immunoreactive TM expressed in the Malpighian-
layer keratinocytes. Immunoreactive TM appears on the suprabasal kerati-
nocytes and disappears at the level of the granular layer. The intensity of 
immunoreactive TM on the epidermis is stronger than the intensity on the 
dermal capillary. Bar, 100 ttm. 
cells of eccrine glands also were stained. MFTM-5 showed the same 
skin staining pattern as MFTM-6, with slightly less nonspecific 
background staining. 
TM in Cultured Cells The immunoreactive TM extracted from 
the keratomed normal epidermis migrated by SDS-P AGE to a posi-
tion identical to that of intact 84-kDa TM derived from either the 
placenta, HUVEC, or STKC (Fig 2). However, we could not de-
tect the immunoreactive TM bands in extracts of the rapidly grow-
ing NHK in low-calcium medium or normal human fibroblasts . 
1 2 3 4 5 6 
- 84 
Figure 2. Western blotting of cellular extracts using MFTM-S. In 
contrast to the undetectable level ofNHK (lane 1), STKC (lane 2), HUVEC 
(lane 3), and normal skin specimen (lane 5) showed immunoreactive bands at 
the molecular weight (84 kDa) identical to the purified placental TM (lane 
4). Normal human fibrobl ast as a negative control (lane 6) showed no 
immunoreactive band (same as NHK). 
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Figure 3. Concentrations of immunoreactive and functional TM 
total protein of the extracts of HUVEC, NHK, STKC, normal 
L::nan fibroblast (NHF), and skin specimem. The immunoreactive 
TM concentration was determined by ELISA specific for T~,. and the func-
tional TM concentration was determined as the cofactor activity for throm-
bin-catalyzed activation of protein C. Data are presented as mean ± SEM. 
TM Concentration of the Extracted Sample~ The n.ormal 
e idermal skin extract and STKC extract contamed slgmficant ~antities of immunoreactive TM: 239 and 298 ng ~M per mg of 
(otal extracted protein, respectively (Fig 3). The ratIO o.f the con-
centrations ofTM per total protein in the STKC and skm extracts 
was even higher than that in HUVEC extract {126 ng T~ pe: mg 
of total protein}. Immunoreactive TM was not detected m either 
NHK or normal human fibroblast extracts by our ELISA system. 
Induction ofTM on Cultured Keratinocytes .NI:IK cultu~ed 
with 1.0 mM calcium KGM for 24 h showed Slg.mfi~antly I.n-
eased TM production associated with morphologic dlfferentla-
c.r The induced TM level was 30 times higher than the level ~~~~ted under low calcium culture conditions (Fig 4). NHK ~ul­
tured in 1 mM calcium ion also showed TM to be present by 1ITI-
munoblotting (Fig 5). 
Protein C-Activating Cofactor Activity The cofactor activity 
for protein C activation by thrombin was detected III the extracts 
from skin specimen, STKC, and HUVEC. From the stan~ard curve 
using the series of diluted recombi.nant TM, the functIOnal TM 
concentrations in the extracts of Sklll, STKC, and HUVEC were 
239,294, and 197 ng/mg of total protein, respect.ively . The ratios 
of the functional TM to the immunoreactive TM m the extracts of 
, kin and STKC were close to 100%; however, by these criteria the ~atio in the HUVEC extract was shown to be over 150% (Fig 3). 
DISCUSSION 
The present st~dies ?n the immun~histochemical distribution of 
TM in the epidermis USlllg two different monoclonal antl-TM 
IgGs, MFTM-5 and MFTM-6, specific for th~ epiderm.al growth 
factor domains of human TM, demonstrated highly slgmficant and 
I reproducible expression of TM in skin. The p.attern of distribution 
ofTM in skin is characteristic. The basal keratll10cytes express little 
or no immunoreactive TM. However, all suprabasilar keratinocytes 
express significant amounts ofT~, and e~pressi.on is readily detect-
able until just before terminal differentiation III the horny layer. 
This finding suggests that keratinocyte TM is closely linked to 
differentiation. 
The contrast between the significant TM concentration in STKC 
extract and the undetectable levels of TM in NHK extract rein-
forces the effect of the cellular differentiation and culture condi-
tions in TM expression. The thirtyfold induction of TM in NHK 
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Figure 4. TM concentrations ofO.S% Triton-X extracts ofNHK cul-
tured with MCDB 153, KGM, and KGM with 1 mM calcium for 
24 h, and measured by ELISA. The samples of high-calcium media 
showed 30 times higher TM content than low-calcium samples. The differ-
entiation by high-calcium environment induced TM expression on NHK. 
Data are presented as mean ± SEM. 
cultures after 24 h in high calcium conditions confirms the differ-
entiation dependency of keratinocyte TM expression. 
In the mouse, the immunohistochemical expression of fetomo-
dulin was reported initially to be present over neural epithelium [2] . 
TM expression on keratinocytes of the same embryologic ectoder-
mal origin is not inconsistent with the distribution of fetomodulin. 
Because a low- molecular-weight, soluble form ofTM is present 
in plasma [8], we considered the possibility that immunoreactive 
epidermal TM was derived from material carried and deposited in 
plasma. However, Western blotting showed that TM in the skin 
and TM in STKC cell extracts have identical molecular weight to 
the full-length endothelial cell TM [1] , strongly suggesting local 
production. These data still did not rule out the possibility that the 
shaved skin samples may have been contaminated by dermal endo-
thelial TM. However, the significant amount ofTM in the extract 
of STKC and in differentiated NHK under high-calcium condi-
tions strongly suggests that TM found in the skin extract is largely 
derived from keratinocytes. 
1 2 3 
Figure S. Western blotting ofkeratinocyte TM induced by high cal-
cium. Placental TM expressed an 84-kDa band (lalle 1). TM was undetect-
able in normal human keratinocytes in low calcium (lalle 2). Keratinocytes 
cultured with 1 111M calcium for 24 h expressed immunoreactive TM (lalle 3) 
of the same molecular weight as placental TM. 
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The co-factor activity of thrombin-catalyzed protein C activation 
is a major and specific biologic activity of TM. Epidermis is not a 
tissue exposed to either blood or thrombin under normal conditions, 
and thus it is possible that epidermal TM has a distinct role. Epider-
mal TM has a molecular size comparable to that of fu ll-length 
functional TM derived from conventional sources, and we found 
significant cofactor activity for thrombin-catalyzed protein C acti-
vation in both skin and cultured STKC extract. An absence of im-
munoreactive thrombin deposition and a significant binding of 
MFTM-S on the normal epidermis suggested vacancy of the throm-
bin-binding sites of epidermal TM. Despite this, epidermal TM 
showed an affinity for thrombin in the protein C-activating assay as 
high as that of the dermal capillary endothelial cells. Thus, even if 
epidermal TM normally does not work as a thrombin receptor in 
normal skin, injury to the skin may allow contact of released TM 
with thrombin in the blood and thus induce its potent functions, 
such as regulation of blood coagulation. 
TM expression in the epidermis was limited strictly to suprabasi-
lar keratinocytes, cells that are committed to terminal differentia-
tion. Epidermal trans glutaminase acts on involucrin, keratolinin, 
loricrin, and filaggrin to enhance formation of the cornified enve-
lope. Polgar et at [9] reported that TM inhibits plasma transgluta-
minase (factor XIII) activation by thrombin. Thus, it is intriguing to 
speculate that epidermal TM influences differentiation by blocking 
epidermal transglutaminase function until keratinocytes reach the 
granular and horny layer. The disappearance of epidermal TM and 
appearance of epidermal trans glutaminase in the granular to horny 
layer are consistent with this hypothesis. 
The present findings suggest that a multifunctional protein, TM, 
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is expressed by keratinocytes and may function as a potent anticoag-
ulant as well as an epidermal differentiation-related protein. 
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